Active

Lobelia Pharma

Switched

BE0471133849

Rechtspersoon Private limited company 1 establishment

Koning Leopold III-laan 128, 8200 Brugge Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

26 year, 6 months

Financials

Financial year 2025

Gross margin

€ 200,850

▲ 154% vs 2024

Profit

Growing

€ 274,161

▲ 10% vs 2024

Debts

Low

€ 2 million

▲ 79% vs 2024

Lobelia Pharma from Brugge, company number BE0471133849, closed financial year 2025 with a result of € 274,161 after tax. For that financial year Lobelia Pharma recorded a gross margin of € 200,850 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 250,338 to € 274,161. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What happened at Lobelia Pharma?

What happened at Lobelia Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 274,161 (▲ 10% vs 2024). Source: NBB ↗
  • Charlotte Delobel became a director. NBB
  • New establishment in Jabbeke. KBO
  • Start of the company according to the CBE. KBO

In short

From € 366,885 profit in 2021 to € 274,161 profit in 2025.

Paid € 163,038 in corporate taxes since 2021.

Best year ever: 2021, with € 366,885 profit.

Paid out € 26,600 in dividends to the owners in total.

A new publication or filing at Lobelia Pharma? We notify you, reason included.

Follow Lobelia Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Charlotte Delobel
Lobelia Pharma

Behind Lobelia Pharma is Charlotte Delobel. It owns 99.2% of Pharma Link itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Charlotte Delobel

Director

Also active at: PHARMA LINK, LOBELIA INVESTMENT AND MANAGEMENT

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Koning Leopold III-laan 128

8200 Brugge

2.099.508.283

Intweg ZN box 3

8490 Jabbeke

Active since 13 April 2000

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0471.133.849
VAT number
BE 0471.133.849
Registered office
Koning Leopold III-laan 128, 8200 Brugge
Names & denominations
Lobelia Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 February 2000
Peppol
Active · Active since 24 Nov 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of Lobelia Pharma?
The enterprise number of Lobelia Pharma is BE0471133849.
What is the address of Lobelia Pharma?
The registered office of Lobelia Pharma is located at Koning Leopold III-laan 128, 8200 Brugge.
When was Lobelia Pharma founded?
Lobelia Pharma was founded on 23 February 2000.
What is the main activity of Lobelia Pharma?
The main activity of Lobelia Pharma is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does Lobelia Pharma have a website?
No website is currently known for Lobelia Pharma.
How much profit did Lobelia Pharma make in 2025?
Lobelia Pharma posted a profit after taxes of € 274,161 in financial year 2025.
What is the revenue of Lobelia Pharma?
As a small company, Lobelia Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 200,850.
Where can I find the annual accounts of Lobelia Pharma?
Lobelia Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Lobelia Pharma?
According to the 2025 annual accounts, the directors of Lobelia Pharma are: Charlotte Delobel.
Who owns Lobelia Pharma?
Behind Lobelia Pharma is Charlotte Delobel. It owns 99.2% of Pharma Link itself.